Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

GSK said on Friday a panel ‍of the European Medicines Agency had backed the use of its ‌respiratory syncytial ‌virus (RSV) ...

Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028 Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, ...

Annual Meeting 2025 Highlights" report has been added to ResearchAndMarkets.com's offering. IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare ...

Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP ...